skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Level of 8-OHdG in drained dialysate appears to be a marker of peritoneal damage in peritoneal dialysis

Original Research

(668) Views  (148) Full article downloads

Authors: Morishita Y, Watanabe M, Hirahara I, Akimoto T, Muto S, Kusano E

Published Date December 2011 Volume 2012:5 Pages 9 - 14
DOI: http://dx.doi.org/10.2147/IJNRD.S27553

Yoshiyuki Morishita, Minami Watanabe, Ichiro Hirahara, Tetsu Akimoto, Shigeaki Muto, Eiji Kusano
Division of Nephrology, Department of Medicine, Jichi Medical University, Tochigi, Japan

Purpose: Peritoneal dialysis (PD) is a successful renal replacement therapy; however, long-term PD leads to structural and functional peritoneal damage. Therefore, the monitoring and estimation of peritoneal function are important in PD patients. Oxidative stress has been implicated as one possible mechanism of peritoneal membrane damage. The aim of this study was to evaluate the association between an oxidative stress marker, 8-hydroxydeoxyguanosine (8-OHdG), and peritoneal damage in PD patients.
Methods: The authors evaluated 8-OHdG in drained dialysate by enzyme immunoassay to investigate the association between 8-OHdG and solute transport rate estimated by peritoneal equilibration test and matrix metalloproteinase-2 (MMP-2) level in 45 samples from 28 PD patients.
Results: The 8-OHdG level was significantly correlated with dialysate:plasma creatine ratio (r = 0.463, P < 0.05) and significantly inversely correlated with D/D0 glucose (where D is the glucose level of peritoneal effluents obtained 4 hours after the injection and D0 is the glucose level obtained immediately after the injection) (r = -0.474, P < 0.05). The 8-OHdG level was also significantly correlated with MMP-2 level (r = 0.551, P < 0.05), but it was not correlated with the age of subjects, the duration of PD, or blood pressure.
Conclusion: The level of 8-OHdG in drained dialysate may be a useful novel marker of peritoneal damage in PD.

Keywords: oxidative stress, solute transport rate, MMP-2, peritoneal equilibration test





 

Other articles by Dr Yoshiyuki Morishita



Readers of this article also read:

Lupus anticoagulant (LA) in pregnant women with history of recurrent fetal loss
A pilot study of the impact of high-frequency chest wall oscillation in chronic obstructive pulmonary disease patients with mucus hypersecretion
Efficacy and safety of prolonged-release melatonin for insomnia in middle-aged and elderly patients with hypertension: a combined analysis of controlled clinical trials
Correlation between radioactivity and chemotherapeutics of the 111In-VNB-liposome in pharmacokinetics and biodistribution in rats
Challenges for heart disease stem cell therapy
Intraocular pressure reduction of fixed combination timolol maleate 0.5% and dorzolamide 2% (Cosopt) administered three times a day
Outcome of the HORIZONS-AMI trial: bivalirudin enhances long-term survival in patients with ST-elevation myocardial infarction undergoing angioplasty
Local pulmonary administration of factor VIIa (rFVIIa) in diffuse alveolar hemorrhage (DAH) – a review of a new treatment paradigm
Nebivolol: impact on cardiac and endothelial function and clinical utility
Emerging drug combinations to optimize renovascular protection and blood pressure goals
  • Testimonials

    "You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio